DE2606516C2 - - Google Patents

Info

Publication number
DE2606516C2
DE2606516C2 DE2606516A DE2606516A DE2606516C2 DE 2606516 C2 DE2606516 C2 DE 2606516C2 DE 2606516 A DE2606516 A DE 2606516A DE 2606516 A DE2606516 A DE 2606516A DE 2606516 C2 DE2606516 C2 DE 2606516C2
Authority
DE
Germany
Prior art keywords
hydrocortisone
propylene glycol
agent
effective
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2606516A
Other languages
German (de)
English (en)
Other versions
DE2606516A1 (de
Inventor
Hyman Hitchin Hertfordshire Gb Yarrow
Martin London Gb Whitefield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diomed Developments Ltd
Original Assignee
DIOMED DEVELOPMENTS Ltd GOSMORE HITCHIN HERTFORDSHIRE GB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIOMED DEVELOPMENTS Ltd GOSMORE HITCHIN HERTFORDSHIRE GB filed Critical DIOMED DEVELOPMENTS Ltd GOSMORE HITCHIN HERTFORDSHIRE GB
Publication of DE2606516A1 publication Critical patent/DE2606516A1/de
Application granted granted Critical
Publication of DE2606516C2 publication Critical patent/DE2606516C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19762606516 1975-02-19 1976-02-18 Entzuendungshemmendes mittel zur lokalen anwendung Granted DE2606516A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7030/75A GB1543907A (en) 1975-02-19 1975-02-19 Steroid compositions

Publications (2)

Publication Number Publication Date
DE2606516A1 DE2606516A1 (de) 1976-09-02
DE2606516C2 true DE2606516C2 (es) 1987-09-17

Family

ID=9825303

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762606516 Granted DE2606516A1 (de) 1975-02-19 1976-02-18 Entzuendungshemmendes mittel zur lokalen anwendung

Country Status (7)

Country Link
JP (1) JPS609486B2 (es)
AU (1) AU502937B2 (es)
DE (1) DE2606516A1 (es)
FR (1) FR2341317A1 (es)
GB (1) GB1543907A (es)
IE (1) IE43270B1 (es)
ZA (1) ZA76980B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
AT389447B (de) * 1983-01-27 1989-12-11 Taisho Pharmaceutical Co Ltd Verfahren zur herstellung einer topischen steroidsalbe
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
WO1996020712A1 (en) * 1994-12-30 1996-07-11 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
GB2302808A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Propylene glycol with low potency corticosteroids for topical treatment of the scalp

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA725898B (en) * 1972-05-30 1973-05-30 Sackler R Iodophor steroid pharmaceutical compositions
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation

Also Published As

Publication number Publication date
GB1543907A (en) 1979-04-11
JPS609486B2 (ja) 1985-03-11
FR2341317A1 (fr) 1977-09-16
FR2341317B1 (es) 1979-06-08
ZA76980B (en) 1977-01-26
IE43270B1 (en) 1981-01-28
JPS51106713A (es) 1976-09-21
DE2606516A1 (de) 1976-09-02
IE43270L (en) 1976-08-19
AU502937B2 (en) 1979-08-16
AU1123276A (en) 1977-08-25

Similar Documents

Publication Publication Date Title
DE2448871C3 (de) Stabilisierung von trans-Retinsäurecreme
DE2046119C2 (de) Mittel zur Behandlung von Akne
DE2747631C3 (de) Salbe
DD159736A5 (de) Verfahren zur herstellung eines pharmazeutischen steroidpraeparates
DE2818553A1 (de) Zusammensetzung zur behandlung von proliferativen hautkrankheiten
CH668188A5 (en) Corticosteroid ointment compsns. - comprise e.g. dexamethasone in poly:alkylene glycol base, and are used esp. for treating rhinitis
EP0367103B1 (de) Topische Salbe
DE2355710C2 (de) Steroidhaltige Creme zur lokalen Behandlung von Hauterkrankungen
DE60004786T2 (de) Verfahren und zusammensetzung zur behandlung von akne
DE2514873C2 (de) Salbengrundlage
DE2818827C2 (de) Mittel zur Behandlung von Psoriasis
DE3411225C2 (es)
DE2606516C2 (es)
DE3139519A1 (de) "topisch verabreichbare pharmazeutische zusammensetzungen, enthaltend anti-inflammatorische steroide"
DE1804801C3 (de) Mittel zur Aknebehandlung
DE2609575C2 (de) Kosmetisches Präparat
DE3402877C2 (es)
DE3941263C1 (es)
DD153759A5 (de) Haarpflegemittel zur aeusseren anwendung
DE2851369A1 (de) Lokalanaesthetische emulsionscreme, verfahren zu deren herstellung und deren verwendung
DE2851544C2 (de) Fluocortolon-haltige Creme
DE3020616C2 (es)
DE2347243A1 (de) Pharmazeutische zusammensetzungen
DE4319096C1 (de) Hormonales Mittel zur Vorbeugung und Behandlung arterieller Erkrankungen beim Mann
DE2604201A1 (de) Kosmetisches haarpflegemittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: DIOMED DEVELOPMENTS LTD., GOSMORE, HITCHIN, HERTFO

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee